New triple therapy before surgery shows promise for tough stomach cancer

NCT ID NCT07182565

First seen Sep 30, 2025 · Last updated May 06, 2026 · Updated 28 times

Summary

This study is for people with a certain type of cancer where the stomach meets the esophagus. It tests if giving a special kind of radiation together with immunotherapy and chemotherapy before surgery is safe and works better. About 84 adults with advanced but removable cancer will take part. The goal is to see if this approach can shrink or eliminate the tumor before the operation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Seventh People's Hospital of Chengdu

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Shangjin Nanfu Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Xiamen Hospital, Sichuan University

    RECRUITING

    Xiamen, Fujian, China

Conditions

Explore the condition pages connected to this study.